Mr. Graham Smith

Since pharmacists are the last stop before reaching the patient, they are ultimately responsible for authenticating both the pedigree and the product before dispensing," said Graham Smith, VP business development, Aegate.

Since pharmacists are the last stop before reaching the patient, they are ultimately responsible for authenticating both the pedigree and the product before dispensing," said Graham Smith, VP business development, Aegate.

Graham Smith, chairman of the distribution group at the European Federation of Pharmaceutical Industries and Associations, said: "Three or four years ago I would have said there was no real necessity [for such a system] as we don't have counterfeit drugs.

However, Graham Smith, chairman of the distribution group at the European Federation of Pharmaceutical Industries and Associations, believes they will be willing to co-operate with Aegate, as long as access to the database is properly regulated.

Mr Smith likens the system to the way credit card purchases are approved over the phone - a process in which several companies have access to information about transactions."We are just using it for a slightly different purpose," he says.

Aegate, the leading pharmaceutical authentication company is supporting its rapid European growth with the appointment of Graham Smith to its management team.Graham takes on the role of Aegate's Business Development Vice President.

London, September 2007 - Aegate, the leading pharmaceutical authentication company is supporting its rapid European growth with the appointment of Graham Smith to its management team.Graham takes on the role of Aegate's Business Development Vice President. With over 15 years experience in the pharmaceutical industry, Graham Smith joins Aegate from AstraZeneca where he was Project Director for the company's European Supply Chain.Graham has also worked as Chairman for the European Federation of Pharmaceutical Industries and Associations (EFPIA) Distribution Group, the body responsible for recent proposals to harmonise coding of pharmaceuticals across the EU with unique, mass serialised numbers using 2D barcode technology. Graham Smith, Business Development Vice President, said "As patient safety and drug counterfeiting continues to be a problem for the global pharmaceutical industry, Aegate's drug authentication system offers a groundbreaking solution for the market.
...
Gary Noon, CEO of Aegate, said: "The appointment of Graham is another step forward for Aegate as we continue to work with leading pharmaceuticals in ensuring global patient safety standards can be met.
...
Graham brings with him excellent knowledge and experience of the pharmaceutical industry and I am delighted to welcome him to our senior management team."